Treatment of hypercholesterolemia.
After discussing the indications for treatment of familial hypercholesterolemia and the importance of a differential diagnosis, the authors describe drug therapy for the disorder with special attention to combined drug regimens. The surgical treatment of hypercholesterolemia and the treatment of homozygous and other forms of hypercholesterolemia are also detailed.
D002792:Cholestyramine Resin / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy*; D006938:Hyperlipoproteinemia Type II / Q000628:therapy; D008077:Lipoproteins, LDL / Q000097:blood; D009355:Neomycin / Q000627:therapeutic use; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D012855:Sitosterols / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use
D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D012855:Sitosterols; D002792:Cholestyramine Resin; D009525:Niacin; D009355:Neomycin; D003084:Colestipol; D011341:Probucol; D013974:Thyroxine